PAX6 and epilepsy: Thus, it is possible that deregulation of GAA, KIF1B and SNCA is involved in pathology of human PAX6 patients with a range of neurological disorders including autism [77], [78], [79], cognitive disorders [80], epilepsy [81] and mental retardation [77].